2m 2m 2m 2m 2m 2m 2m
GT BIOPHARMA (GTBP)
NASDAQ
$0.29+$0.0004 (+0.14%)
Price as of Aug 21, 2026 7:25 PM EDT- $12.8MMarket Cap
- -74.00%1-Year Change
- BiotechnologyIndustry
GT BIOPHARMA (GTBP)
$0.29+$0.0004 (+0.14%)
GTBP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.29 | ||
Change | +$0.007 (+2.34%) | ||
Open | $0.28 | ||
High | $0.29 | ||
Low | $0.28 | ||
Previous Close | $0.28 | ||
Volume | 253,343 | ||
30-Day Average Volume | 447,581 | ||
1-Week Change | -2.50% | ||
1-Month Change | -19.45% | ||
1-Year Change | -74.00% | ||
3-Year Change | -96.30% | ||
5-Year Change | -99.87% | ||
Fundamentals | |||
Shares Outstanding | 44.3M | ||
Total Assets | $5.8M | ||
Market Cap | $12.8M | ||
Enterprise Value | $7.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.6M | ||
Free Cash Flow | -$4.3M | ||
EBIT | -$4.6M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $3.6M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 02/05/2024 | ||
Earnings & Revenue